Smith & Nephew (LON:SN) Stock Price Passes Above 200-Day Moving Average of $1,055.41

Smith & Nephew plc (LON:SN)’s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,055.41 ($13.94) and traded as high as GBX 1,199.50 ($15.85). Smith & Nephew shares last traded at GBX 1,196 ($15.80), with a volume of 1,916,994 shares trading hands.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a “buy” rating and set a £145 ($191.55) price objective on shares of Smith & Nephew in a report on Monday, August 5th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, Smith & Nephew currently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 3,956.20 ($52.26).

Smith & Nephew Price Performance

The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84. The firm has a market cap of £10.38 billion, a price-to-earnings ratio of 4,407.41, a PEG ratio of 0.48 and a beta of 0.62. The stock has a 50-day moving average price of GBX 1,145.58 and a 200 day moving average price of GBX 1,055.41.

Smith & Nephew Cuts Dividend

The company also recently declared a dividend, which will be paid on Friday, November 8th. Shareholders of record on Thursday, October 3rd will be given a dividend of $0.14 per share. This represents a yield of 1%. The ex-dividend date of this dividend is Thursday, October 3rd. Smith & Nephew’s dividend payout ratio (DPR) is 11,111.11%.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.